Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 682INDUSTRY 367NIH 182NETWORK 37OTHER_GOV 13FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 20Thoracic 5Other hematologic neoplasm 5Lymphoid 5Gastrointestinal 4Head & Neck 2Dermatologic 2CNS 2Tumor-Agnostic 1Plasma cell 1Myeloid 1Classical hematology 1Breast 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Keratosis, Actinic 1

Interventions

Imipramine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × FED × Dermatologic × Clear all
NCT06778434 2025-12-22

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

VA Office of Research and Development

Phase 2 Recruiting
48 enrolled
Dermatologic

Keratosis, Actinic

NCT00099593 2015-03-25

Immunization Against Tumor Cells in Sezary Syndrome

FDA Office of Orphan Products Development

Phase 2 Completed
17 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡